Viridian Therapeutics, Inc. · NASDAQ:VRDN
Kynam Capital Management, LP reported a 5.70% stake in Viridian Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Kynam Capital Management, LP reported a 5.70% stake in Viridian Therapeutics, Inc., 0 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 5.70%
- Shares
- 0
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Kynam Capital Management, LP | 5.70% | 0 |
| Kynam Capital Management GP, LLC | 5.70% | 0 |
| Yue Tang | 5.70% | 0 |
Source
Related
- Viridian Therapeutics, Inc.
- Kynam Capital Management, LP
- Viridian Therapeutics, Inc. shareholders
- Schedule 13G/A · Kynam Capital Management, LP · Feb 17, 2026
- Schedule 13G · Kynam Capital Management, LP · May 15, 2025
- Form 4 · Tousignant Jennifer · Aug 20, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Aug 20, 2026
- Form 4 · Tripuraneni Radhika · Aug 18, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2026